Abdul Hadi Kaakour, MD
Ophthalmology · Nashville, TNNPI 1487004396
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,589 of the $4,051 with a category attached, or 88.6%. It is spread thinly across 15 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,864 and has fallen 83.4% since, to $310 in 2025.
Across 53 payments — averaging $76.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$926
- Apellis Pharmaceuticals, Inc.$839
- Novartis$488
- Regeneron$466
- Genentech USA, Inc.$263
- AbbVie$169
- plus $900 from 9 others
Across 4 payments — averaging $3828.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$15K
What the payments were for
- Travel & lodging$46211%
- Food & beverage$3,58989%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 11 | $926 |
| Apellis Pharmaceuticals, Inc. | 12 | $839 |
| Novartis | 4 | $488 |
| Regeneron | 2 | $466 |
| Genentech USA, Inc. | 3 | $263 |
| AbbVie(2 entities) | 3 | $169 |
| Alimera Sciences, Inc. | 3 | $162 |
| Genentech, Inc. | 3 | $143 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $106 |
| Eyepoint US, Inc. | 3 | $93 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $89 |
| Bausch & Lomb Americas Inc. | 3 | $69 |
| Dutch Ophthalmic, USA | 1 | $62 |
| ANI Pharmaceuticals, Inc. | 2 | $51 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,051 in reported general payments places this provider in the 80th percentile of 323 ophthalmology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 25 | $698 |
| Ketorolac Tromethamine | 14 | $596 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 11 | $174 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Nashville
- Deborah ShermanNashville$3M
- Brian BiesmanNashville$630K
- Edward ChaumNashville$158K
- Jeffrey HornNashville$106K
- Avni FinnNashville$57K
- Louise MawnNashville$56K
- Jeffrey KammerNashville$30K
- Gary JerkinsNashville$15K
- Allison SmithNashville$13K
- Christine ShiehNashville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.